Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.48 (
transcriptase
)
9,479
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Arabidopsis thaliana
(
Arabidopsis
) has been used extensively as a heterologous system for molecular manipulation to genetically characterize both dicotyledonous and monocotyledonous plant species. Here, we report on
Arabidopsis
transformant lines molecularly manipulated to over-accumulate the small regulatory RNA microRNA397 (miR397) from the emerging C
4
monocotyledonous grass model species
Setaria viridis
(
S. viridis
). The generated transformant lines, termed
SvMIR397
plants, displayed a range of developmental phenotypes that ranged from a mild, wild-type-like phenotype, to a severe, full dwarfism phenotype. Reverse
transcriptase
quantitative polymerase chain reaction (RT-qPCR)-based profiling of the
SvMIR397
transformant population revealed a strong correlation between the degree of miR397 over-accumulation, repressed
LACCASE
(
LAC
) target gene expression, reduced lignin content, and the severity of the developmental phenotype displayed by
SvMIR397
transformants. Further, exposure of
SvMIR397
transformants to a 7-day regime of
salt
stress revealed the
SvMIR397
transformant lines to be more sensitive to the imposed stress than were wild-type
Arabidopsis
plants. Taken together, the findings reported here via the use of
Arabidopsis
as a heterologous system show that the
S. viridis
miR397 small regulatory RNA is able to repress the expression of three
Arabidopsis LAC
genes which led to reduced lignin content and increased
salt
stress sensitivity.
...
PMID:Molecular Manipulation of MicroRNA397 Abundance Influences the Development and Salt Stress Response of
Arabidopsis thaliana
. 3311 7
The
RNA-dependent RNA polymerase
(RdRp) is a key enzyme which regulates the viral replication of SARS-CoV-2. Remdesivir (RDV) is clinically used drug which targets RdRp, however its mechanism of action remains elusive. This study aims to find out the binding dynamics of active Remdesivir-triphosphate (RDV-TP) to RdRp by means of molecular dynamics (MD) simulation. We built a homology model of RdRp along with RNA and manganese ion using RdRp hepatitis C virus and recent SARS-CoV-2 structures. We determined that the model was stable during the 500 ns MD simulations. We then employed the model to study the binding of RDV-TP to RdRp during three independent 500 ns MD simulations. It was revealed that the interactions of protein and template-primer RNA were dominated by
salt
bridge interactions with phosphate groups of RNA, while interactions with base pairs of template-primer RNA were minimal. The binding of RDV-TP showed that the position of phosphate groups was at the entry of the NTP channel and it was stabilized by the interactions with K551, R553, and K621, while the adenosine group on RDV-TP was pairing with U2 of the template strand. The manganese ion was located close to D618, D760, and D761, and helps in stabilization of the phosphate groups of RDV-TP. Further we identified three hits from the natural product database that pose similar to RDV-TP while having lower binding energies than that of RDV-TP, and that SN00359915 had binding free energy about three times lower than that of RDV-TP.
...
PMID:Mechanistic insight on the remdesivir binding to RNA-Dependent RNA polymerase (RdRp) of SARS-cov-2. 3326 Jan 3
<< Previous
1
2
3
4
5
6
7
8
9